• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

建模评估疫苗接种对非洲国家 COVID-19 的影响。

Modelling the impact of vaccination on COVID-19 in African countries.

机构信息

Department of Decision Sciences, University of South Africa, Pretoria, South Africa.

Department of Mathematics, University of Cape Coast, Cape Coast, Ghana.

出版信息

PLoS Comput Biol. 2024 Oct 23;20(10):e1012456. doi: 10.1371/journal.pcbi.1012456. eCollection 2024 Oct.

DOI:10.1371/journal.pcbi.1012456
PMID:39441851
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11498717/
Abstract

The rapid development of vaccines to combat the spread of COVID-19, caused by the SARS-CoV-2 virus, is a great scientific achievement. Before the development of the COVID-19 vaccines, most studies capitalized on the available data that did not include pharmaceutical measures. Such studies focused on the impact of non-pharmaceutical measures such as social distancing, sanitation, use of face masks, and lockdowns to study the spread of COVID-19. In this study, we used the SIDARTHE-V model, an extension of the SIDARTHE model, which includes vaccination rollouts. We studied the impact of vaccination on the severity of the virus, specifically focusing on death rates, in African countries. The SIRDATHE-V model parameters were extracted by simultaneously fitting the COVID-19 cumulative data of deaths, recoveries, active cases, and full vaccinations reported by the governments of Ghana, Kenya, Mozambique, Nigeria, South Africa, Togo, and Zambia. Using South Africa as a case study, our analysis showed that the cumulative death rates declined drastically with the increased extent of vaccination drives. Whilst the infection rates sometimes increased with the arrival of new coronavirus variants, the death rates did not increase as they did before vaccination.

摘要

疫苗的快速发展是对抗由 SARS-CoV-2 病毒引起的 COVID-19 传播的一项重大科学成就。在 COVID-19 疫苗开发之前,大多数研究都利用了不包括药物措施的现有数据。这些研究主要关注非药物措施(如社交距离、卫生、使用口罩和封锁)对 COVID-19 传播的影响。在这项研究中,我们使用了 SIDARTHE-V 模型,这是 SIDARTHE 模型的扩展,其中包括疫苗接种的推广。我们研究了疫苗接种对病毒严重程度的影响,特别是在非洲国家的死亡率方面。通过同时拟合加纳、肯尼亚、莫桑比克、尼日利亚、南非、多哥和赞比亚政府报告的 COVID-19 死亡、康复、活跃病例和全面疫苗接种的累积数据,提取了 SIRDATHE-V 模型参数。利用南非作为案例研究,我们的分析表明,随着疫苗接种力度的增加,累计死亡率急剧下降。虽然感染率有时会随着新的冠状病毒变体的出现而上升,但死亡率并没有像接种疫苗前那样上升。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/110e/11498717/d3945b4adc64/pcbi.1012456.g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/110e/11498717/97d1e49e6ef0/pcbi.1012456.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/110e/11498717/39b87eb3567f/pcbi.1012456.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/110e/11498717/b248644e85d4/pcbi.1012456.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/110e/11498717/321b5f18bd62/pcbi.1012456.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/110e/11498717/f36a5b51e823/pcbi.1012456.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/110e/11498717/8ec5470f551f/pcbi.1012456.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/110e/11498717/edb8a07a5a89/pcbi.1012456.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/110e/11498717/29d277dfc0ac/pcbi.1012456.g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/110e/11498717/c8acbb574d76/pcbi.1012456.g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/110e/11498717/b62da426713f/pcbi.1012456.g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/110e/11498717/865cc93a5466/pcbi.1012456.g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/110e/11498717/d3945b4adc64/pcbi.1012456.g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/110e/11498717/97d1e49e6ef0/pcbi.1012456.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/110e/11498717/39b87eb3567f/pcbi.1012456.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/110e/11498717/b248644e85d4/pcbi.1012456.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/110e/11498717/321b5f18bd62/pcbi.1012456.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/110e/11498717/f36a5b51e823/pcbi.1012456.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/110e/11498717/8ec5470f551f/pcbi.1012456.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/110e/11498717/edb8a07a5a89/pcbi.1012456.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/110e/11498717/29d277dfc0ac/pcbi.1012456.g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/110e/11498717/c8acbb574d76/pcbi.1012456.g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/110e/11498717/b62da426713f/pcbi.1012456.g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/110e/11498717/865cc93a5466/pcbi.1012456.g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/110e/11498717/d3945b4adc64/pcbi.1012456.g012.jpg

相似文献

1
Modelling the impact of vaccination on COVID-19 in African countries.建模评估疫苗接种对非洲国家 COVID-19 的影响。
PLoS Comput Biol. 2024 Oct 23;20(10):e1012456. doi: 10.1371/journal.pcbi.1012456. eCollection 2024 Oct.
2
A SARS-CoV-2 Surveillance System in Sub-Saharan Africa: Modeling Study for Persistence and Transmission to Inform Policy.撒哈拉以南非洲的新冠病毒监测系统:关于持续存在和传播以指导政策的建模研究
J Med Internet Res. 2020 Nov 19;22(11):e24248. doi: 10.2196/24248.
3
COVID-19 vaccine access in Africa: Global distribution, vaccine platforms, and challenges ahead.非洲的 COVID-19 疫苗获取:全球分配、疫苗平台和未来挑战。
Immunity. 2021 Jul 13;54(7):1353-1362. doi: 10.1016/j.immuni.2021.06.017.
4
COVID-19 Cases and Hospitalizations by COVID-19 Vaccination Status and Previous COVID-19 Diagnosis - California and New York, May-November 2021.COVID-19 病例和住院情况按 COVID-19 疫苗接种状况和既往 COVID-19 诊断情况划分-加利福尼亚州和纽约州,2021 年 5 月至 11 月。
MMWR Morb Mortal Wkly Rep. 2022 Jan 28;71(4):125-131. doi: 10.15585/mmwr.mm7104e1.
5
COVID-19 vaccine hesitancy in Africa: a scoping review.非洲的 COVID-19 疫苗犹豫:范围综述。
Glob Health Res Policy. 2022 Jul 19;7(1):21. doi: 10.1186/s41256-022-00255-1.
6
Using syndromic measures of mortality to capture the dynamics of COVID-19 in Java, Indonesia, in the context of vaccination rollout.利用综合征死亡率指标来捕捉印度尼西亚爪哇 COVID-19 的动态,考虑到疫苗接种的开展情况。
BMC Med. 2021 Jun 18;19(1):146. doi: 10.1186/s12916-021-02016-2.
7
Understanding COVID-19 in Africa.了解非洲的 COVID-19 疫情。
Nat Rev Immunol. 2021 Aug;21(8):469-470. doi: 10.1038/s41577-021-00579-y. Epub 2021 Jun 24.
8
Modeling of Future COVID-19 Cases, Hospitalizations, and Deaths, by Vaccination Rates and Nonpharmaceutical Intervention Scenarios - United States, April-September 2021.基于疫苗接种率和非药物干预情景的未来 COVID-19 病例、住院和死亡建模-美国,2021 年 4 月至 9 月。
MMWR Morb Mortal Wkly Rep. 2021 May 14;70(19):719-724. doi: 10.15585/mmwr.mm7019e3.
9
Upstream factors impacting COVID-19 vaccination rates across Africa: A systematic review protocol.影响非洲 COVID-19 疫苗接种率的上游因素:系统评价方案。
PLoS One. 2024 Sep 25;19(9):e0310884. doi: 10.1371/journal.pone.0310884. eCollection 2024.
10
Modeling vaccination rollouts, SARS-CoV-2 variants and the requirement for non-pharmaceutical interventions in Italy.意大利疫苗接种推广、新冠病毒变异株及非药物干预措施需求的建模
Nat Med. 2021 Jun;27(6):993-998. doi: 10.1038/s41591-021-01334-5. Epub 2021 Apr 16.

本文引用的文献

1
Allergic reactions to the Ad26.COV2.S vaccine in South Africa.南非对Ad26.COV2.S疫苗的过敏反应。
J Allergy Clin Immunol Glob. 2021 Dec 9;1(1):2-8. doi: 10.1016/j.jacig.2021.12.002. eCollection 2022 Feb.
2
Inequality in COVID-19 vaccination in Africa.非洲新冠疫苗接种的不平等现象。
J Public Health Afr. 2023 May 24;14(7):2353. doi: 10.4081/jphia.2023.2353. eCollection 2023 Jul 26.
3
COVID-19 vaccination rollout in the World Health Organization African region: status at end June 2022 and way forward.世界卫生组织非洲区域的 COVID-19 疫苗接种工作进展:截至 2022 年 6 月底的状况和前进方向。
Epidemiol Infect. 2022 Jul 12;150:e143. doi: 10.1017/S0950268822001212.
4
The COVID-19 Vaccination and Vaccine Inequity Worldwide: An Empirical Study Based on Global Data.《COVID-19 疫苗接种与全球疫苗不平等:基于全球数据的实证研究》。
Int J Environ Res Public Health. 2022 Apr 26;19(9):5267. doi: 10.3390/ijerph19095267.
5
Genetic diversity of SARS-CoV-2 infections in Ghana from 2020-2021.加纳 2020-2021 年 SARS-CoV-2 感染的遗传多样性。
Nat Commun. 2022 May 6;13(1):2494. doi: 10.1038/s41467-022-30219-5.
6
Estimating the cost of COVID-19 vaccine deployment and introduction in Ghana using the CVIC tool.利用 CVIC 工具估计加纳 COVID-19 疫苗部署和引入的成本。
Vaccine. 2022 Mar 15;40(12):1879-1887. doi: 10.1016/j.vaccine.2022.01.036. Epub 2022 Feb 4.
7
Unmet need for COVID-19 vaccination coverage in Kenya.肯尼亚 COVID-19 疫苗接种覆盖率未满足需求。
Vaccine. 2022 Mar 18;40(13):2011-2019. doi: 10.1016/j.vaccine.2022.02.035. Epub 2022 Feb 14.
8
Determinants of COVID-19 vaccine uptake and barriers to being vaccinated among first-round eligibles for COVID-19 vaccination in Eastern Ethiopia: A community based cross-sectional study.埃塞俄比亚东部新冠疫苗首轮接种合格者中新冠疫苗接种率的决定因素及接种障碍:一项基于社区的横断面研究
SAGE Open Med. 2022 Feb 8;10:20503121221077585. doi: 10.1177/20503121221077585. eCollection 2022.
9
COVID-19 Vaccines: Current Conditions and Future Prospects.新冠疫苗:现状与未来展望
Biology (Basel). 2021 Sep 26;10(10):960. doi: 10.3390/biology10100960.
10
One year after first case of COVID-19 in Ghana: epidemiology, challenges and accomplishments.加纳首例 COVID-19 病例一年后:流行病学、挑战和成就。
Pan Afr Med J. 2021 Aug 4;39:226. doi: 10.11604/pamj.2021.39.226.29069. eCollection 2021.